Revance Therapeutics Inc
NASDAQ:RVNC

Watchlist Manager
Revance Therapeutics Inc Logo
Revance Therapeutics Inc
NASDAQ:RVNC
Watchlist
Price: 3.65 USD Market Closed
Market Cap: $381m

Profitability Summary

Revance Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Revance Therapeutics Inc

Margins Comparison
Revance Therapeutics Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Revance Therapeutics Inc
NASDAQ:RVNC
382.9m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Revance Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Revance Therapeutics Inc
NASDAQ:RVNC
382.9m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Revance Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate